Amgen (AMGN) Earnings Analysis

Amgen (AMGN) has no confirmed upcoming earnings date. Last quarter (2026-04-30) it beat with EPS 5.15 USD vs 4.77 USD est (+8%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 25.28.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does AMGN next report earnings?

No confirmed upcoming earnings date is currently scheduled for AMGN. This page updates as the calendar is published.

AMGN earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-305.15 USD4.77 USD+8%Beat
2026-02-035.29 USD4.73 USD+11.8%Beat
2025-05-014.9 USD4.27 USD+14.8%Beat
2025-02-045.31 USD5.04 USD+5.4%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

AMGN valuation and analyst view

Trailing P/E25.28
Trailing EPS14.444 USD
Price / book21.51
Dividend yield2.68%
Market cap198.21B
Analyst consensusBuy (22 buy / 13 hold / 3 sell)
Avg price target362.7 USD

Related research pages

Frequently asked questions

When is Amgen (AMGN)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for AMGN. This page updates as the calendar is published.

Did AMGN beat earnings last quarter?

In its 2026-04-30 report, AMGN posted EPS of 5.15 USD versus a 4.77 USD estimate — a beat of 8%.

What is AMGN's earnings track record?

Over the last 4 reported quarters with consensus data, AMGN beat estimates 4 times (100%).

What is AMGN's current P/E ratio and EPS?

AMGN trades at a trailing P/E of 25.28 on trailing EPS of 14.444444444444445 USD.

What do analysts rate AMGN?

Analyst consensus is "Buy" across 38 ratings (0 strong buy, 22 buy, 13 hold, 3 sell, 0 strong sell). Average 12-month price target: 362.7 USD.